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Abstract
Background: RNA interference (RNAi) is an evolutionarily conserved process that functions to
inhibit gene expression. The use of RNAi in mammals as a tool to study gene function has rapidly
developed in the last couple of years since the discovery that the function-inhibiting units of RNAi
are short 21–25 nt double-stranded RNAs (siRNAs) derived from their longer template. The use
of siRNAs allows for gene-specific knock-down without induction of the non-specific interferon
response in mammalian cells. Multiple systems have been developed to introduce siRNAs into
mammals. One of the most appealing of these techniques is the use of vectors containing
polymerase III promoters to drive expression of hairpin siRNAs. However, there are multiple
limitations to using hairpin siRNA vectors including the observation that some are unstable in
bacteria and are difficult to sequence.
Results: To circumvent the limitation of hairpin siRNA vectors we have developed a convergent
opposing siRNA expression system called pHippy. We have generated pHippy vectors or
expression cassettes that knock down the expression of both reporter and endogenous genes. As
a proof of principle that pHippy can be used to generate random siRNA libraries, we generated a
small siRNA library against PGL3 luciferase and demonstrated that we could recover functional
siRNAs that knock down PGL3 luciferase.
Conclusions: siRNA is a powerful tool to study gene function. We have developed a new vector
with opposing convergent promoters for the expression of siRNAs, which can be used to knock
down endogenous genes in a high throughput manner or to perform functional screening with
random or cDNA-derived siRNA libraries.
Background
RNA interference is an evolutionarily conserved process
that functions to inhibit gene expression [1,2]. The phe-
nomenon of RNAi was first described by Fire et al. six
years ago. In seminal experiments they injected double
stranded RNA (dsRNA) into Caenorhabditis elegans, which
led to efficient sequence-specific gene silencing of the
mRNA that was complimentary to the dsRNA [3]. RNAi
has also been described in plants as a phenomenon called
post-transcriptional gene silencing (PTGS) which is likely
used as a viral defense mechanism [4-6]. Introduction of
long dsRNA into a variety of organisms such as Drosophila,
Trypanosoma, and pre-implanted mouse oocytes has been
shown to specifically inhibit the complimentary mRNA
[5-7]. However, in somatic mammalian cells long dsRNA
also induces the interferon response, which globally
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inhibits translation by induction of the kinase, PKR, and
2', 5'-oligoadenylate synthetase. This has limited the use
of RNAi as a tool to study gene function in mammalian
cells [8,9].
The first indication that the molecules that regulate PTGS
were short RNAs processed from longer dsRNA was the
identification of short 21 nt to 22 nt dsRNA derived from
the longer dsRNA in plants [6]. This observation was reca-
pitulated in Drosophila embryo extracts where long dsRNA
was found processed into 21–25 nt short RNA by the
RNase III type enzyme, Dicer [9-11]. These observations
led Elbashir et al. to test if synthetic 21–25 nt synthetic
dsRNAs function to specifically inhibit gene expression in
Drosophila embryo lysates and mammalian cell culture [9-
11]. They demonstrated that siRNA had the ability to spe-
cifically inhibit gene expression in mammalian cell cul-
ture without induction of the interferon response. These
observations led to the development of many techniques
for the specific knockdown of genes in mammalian cell
culture.
Of these techniques, plasmid-based systems that generate
hairpin siRNAs are very appealing [12-15]. These vectors
are fairly inexpensive and have been shown to inhibit
multiple genes both transiently and in long-term experi-
ments. However, hairpin vectors suffer from multiple lim-
itations. Hairpins can be hard to synthesize in bacteria,
difficult to sequence, and the oligos needed to generate
them can be costly and error-prone [14,16]. In addition,
the hairpin length and sequence can affect the ability of
the siRNA to inhibit gene expression [12,17]. Although
cDNA-based siRNA libraries have been generated in hair-
pin vectors, generation of these libraries is technically dif-
ficult and heterologous hairpin loops have to be added to
the siRNA [18,19]. The latter may increase off-target
effects of the siRNAs generated from these strategies.
To circumvent the limitations of hairpin siRNA expression
vectors, we have generated a siRNA expression vector,
which expresses siRNAs from convergent opposing pro-
moters. We have named this vector "HI inverted U6 pro-
moter plasmid," or pHippy. Short double-stranded
oligonucleotides can be easily and efficiently introduced
into this vector to knock down any mRNA, or siRNA
expression cassettes can be generated in a high throughput
manner by PCR. We demonstrate that pHippy can gener-
ate functional siRNAs in mammalian cells that knock
down the expression of both ectopic reporters and endog-
enous genes. Because both strands of the siRNA are tran-
scribed from the same template DNA, random or cDNA-
derived siRNA libraries can easily be generated in pHippy.
As a proof of principle we generated a random pool of siR-
NAs against PGL3 luciferase and screened this library for
silencing activity. This library was deconvoluted to iden-
tify functional vectors that have the original siRNA
sequence against PGL3 luciferase. Although this is only a
partial random library to a previous efficacious siRNA,
this demonstrates that random siRNA libraries can be
used to functionally identify genes.
Results and discussion
Design of an opposing convergent siRNA expression 
vector, pHippy
pHippy contains two opposing polymerase III (pol. III)
promoters to drive the expression of both strands of a
template DNA cloned in between the promoters. To cir-
cumvent generating an inverted repeat, which can cause
plasmid instability in E. coli, the human H1 and human
U6 promoters were used instead of two H1 or U6 promot-
ers. Both the H1 and U6 promoter were modified to con-
tain a five Thymidine pol. III termination sequence at the
-5 to -1 position and a BsmBl site at the -12 to -6 position
(Fig. 1a). This does not appear to affect the ability of either
promoter to drive expression of RNA nor does it appear to
affect the transcriptional start site. The BsmBl cuts 5 bases
downstream of its recognition site and in the case of
pHippy will leave 4 Thymidine 3' overhangs at -1 to -4 of
both U6 and H1 promoters. Digestion of pHippy with
BsmB1 renders the two ends incompatible for ligation
and hence gives a very low level of background when
ligated. More than 25 double stranded oligos have been
cloned into pHippy with nearly 100% cloning efficiency
(data not shown). The target sequence for any mRNA can
be cloned into pHippy and the DNA will be transcribed
from both strands and form a double stranded RNA with
two 5'Uridine overhangs, which closely resembles func-
tional siRNA produced by Dicer [11,12,20,21]. This vector
system can be used to generate siRNA to target any tran-
script or open reading frame (ORF) (Fig. 1b). Pools of siR-
NAs for specific mRNAs can be generated by restriction
enzyme or DNase digestion of a cDNA for any gene and
subsequent cloning of the small fragments into pHippy
(Fig. 1b). This circumvents the need to find specific tar-
gets, which can be time consuming and costly. In addi-
tion, libraries of siRNAs can be generated by restriction
enzyme or DNase digestion of cDNA libraries or by clon-
ing of random oligos into pHippy (Fig. 1b). These librar-
ies can be used to screen populations of transfected cells
for phenotypic changes and the cells with the desired phe-
notype can be recovered, allowing the siRNA construct to
be rescued and characterized. This type of screen allows an
unbiased means to identify genes involved in diverse bio-
logical processes.
pHippy efficiently inhibits the ectopic expression of 
reporter genes
To determine if pHippy produces functional siRNAs, we
generated a pHippy vector against PGL3 luciferase
(pHippyPGL3luc) from a previously reported syntheticBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/16
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Depiction of the pHippy dual siRNA expression vector and some of its possible uses Figure 1
Depiction of the pHippy dual siRNA expression vector and some of its possible uses. a, pHippy has convergent opposing 
Human H1 and U6 polymerase III promoters that drive expression of both strands of any template cloned in between the 
BsmB 1 cloning sites. pHippy also contains the Puc origin and the Zeocin-resistance gene for propagation and replication in bac-
teria. As depicted the H1 and U6 promoters were modified to contain a polymerase III termination signal (TTTTT) between 
the -5 to -1 position of the promoter, and BsmBl sites. BsmBl is a type II restriction enzyme, which cuts outside of its recogni-
tion sequence and will in the case of pHippy leaves 3' TTTT overhangs on both strands of the plasmid as depicted. 19 nt target 
siRNA can be cloned into pHippy as double stranded oligos by addition of AAAA to the 5' ends of the oligos as depicted b. b, 
Proposed uses for the pHippy siRNA vector system.
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a, Luciferase assay to determine the efficiency of target suppression by the pHippy vector Figure 2
a, Luciferase assay to determine the efficiency of target suppression by the pHippy vector. Hairpin siRNA expression vectors 
were generated against PGL3 luciferase with either the U6 (U6GPL31ucHP) or H1 (HlPGL31ucHP) promoters. For compari-
son, pHippy siRNA vectors were generated against PGL3 luciferase (pHippyPGL31uc) or against EGFP (pHippyEGFP). 293T 
cells were transfected with the constructs shown and assayed for luciferase activity 24 hours later. The absolute levels of PGL3 
luciferase were ~100,000 relative light units (RLUs) which was set at 100%. All experiments were normalized for transfection 
efficiency with an expression vector for Renilla luciferase. The average normalized PGL3 luciferase levels and standard devia-
tion are shown for 3 experiments. b, EGFP fluorescent assay to monitor the suppression of protein expression by pHip-
pyEGFP. 293T cells were co-transfected with empty pHippy or pHippyEGFP and expression vectors for DsRED and EGFP. 
Confocal image of EGFP and EGFP merged with DsRED are shown. One representative experiment is shown.
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siRNA directed against PGL3 luciferase [9]. Using the
same target sequence against PGL3 luciferase, we made
two hairpin siRNA vectors, with one driven from the U6
promoter (U6PGL31ucHP) and one driven from the H1
promoter (HIPGL3lucHP). To determine the efficiency of
inhibition of the PGL3 luciferase target by the various
siRNA vectors, 293T cells were transfected with a cocktail
of PGL3 luciferase, Renilla luciferase, and a siRNA vector
driving a hairpin or a pHippy siRNA. After normalization
for transfection with Renilla luciferase, the empty pHippy
vector gave similar luciferase levels as cells transfected
with luciferase alone, and this level was set to 100% luci-
ferase activity (Fig 2a). Both of the vectors that express
hairpin RNAs against PGL3 luciferase significantly inhib-
ited luciferase expression (Fig. 2a). The pHippy vector
with the target sequence against PGL3 luciferase also
inhibited expression of PGL3 luciferase. Moreover, at the
same concentration of DNA transfected, pHippyPGL31uc
is more efficient at inhibiting Luciferase expression than
either of the hairpin vectors. Specifically, at 30 ng of DNA
transfected PHippyPGL31uc is 2–4 times more efficient
than inhibition of PGL3 luciferase by the vectors that gen-
erate hairpin RNAs. Although pHippy-generated siRNA
appears to be more efficient than hairpin generated
siRNA, a more detailed side by side comparison would
have to be conducted to establish specific activities.
To determine if pHippy generates sequence-specific inhib-
itory siRNAs, a vector was designed against EGFP. pHip-
pyEGFP did not inhibit the expression of PGL3 Luciferase
(Fig. 2a). However, it inhibited the expression of EGFP
(Fig. 2b). This not only establishes that the inhibition of
expression of EGFP and Luciferase is gene-specific, but
also demonstrates that pHippy can theoretically be used
to knock down the expression of any gene. Supportingly,
to date we have knocked down expression of more than
10 unique genes with pHippy (data not shown). We have
not observed off-target effect of these siRNAs, though we
have not systematically screened for such potential effects.
We speculate that siRNAs generated by pHippy are less
likely to generate off-target effects because there are no
heterologous sequences included in the siRNA, such as a
hairpin loop. On average we have found that 3–4 con-
structs with unique target sequences have to be tested to
obtain functional siRNA, which is very similar to other
siRNA systems.
pHippy efficiently inhibits the expression of endogenous 
genes
To determine if pHippy can be used to inhibit the expres-
sion of endogenous genes, five pHippy constructs were
generated against the human Low-density Lipoprotein
Receptor-related Protein 6 (LRP6). To first demonstrate
that the constructs could inhibit expression of ectopic
LRP6, they were screened for their ability to inhibit expres-
sion of a fusion protein consisting of LPR6 and Renilla
luciferase (LRP6Rluc). This fusion of a target gene to
Renilla luciferase allows for rapid quantitative assessment
of the efficiency of any given siRNA construct. Three of the
five pHippy constructs generated against LRP6 inhibit
LRP6Rluc expression by more than 50% (Fig. 3a). To test
if expression of endogenous LRP6 was also inhibited, we
determined if any of the pHippy constructs altered an
indirect readout of the biological function of LRP6.
Briefly, LRP6 is part of the Wnt receptor signaling com-
plex, and it is required to receive and transduce Wnt sign-
aling to downstream components in the Wnt signaling
cascade [22]. Thus, the biological function of LRP6 culmi-
nates in the activation of β-catenin-mediated transcrip-
tion, which can be efficiently measured by activation of
the Super(8X)Topflash reporter [23]. To test if LRP6 is
required for Wnt signal transduction in human cells, 293T
cells were co-transfected with a cocktail of Super(8X)Top-
flash, Renilla luciferase, and the five pHippy constructs
directed against LRP6 or control pHippy constructs. 24
hours after transfection the cells were treated with Wnt3a-
conditioned media to activate Wnt signaling and thus the
expression of Super(8X)Topflash, then cultured for an
additional 24 hours. After normalization for transfection
with Renilla luciferase, the cells transfected with empty
pHippy or pHippyEGFP were set to 1 fold activation (Fig.
3b). Treatment with Wnt3a increases the reporter activa-
tion about 100-fold (Fig. 3b). Co-transfection of some of
the pHippyLPR6 constructs inhibited Wnt3a activation of
Super(8X)Topflash more than 50% (Fig 3b). Strikingly,
there was a strict correlation between the ability of the
pHippyLRP6 constructs to inhibit the expression of
LRP6Rluc and the ability to inhibit Wnt3a activation of
Super(8X)Topflash (Fig. 3a,3b). These experiments dem-
onstrate that pHippy constructs have the ability to inhibit
the expression and thus the biological function of endog-
enous genes.
pHippy expression cassettes can easily be generated in a 
high throughput manner by PCR
To generate pHippy siRNA constructs in a rapid manner,
a PCR method was devised that incorporates the U6 and
H1 promoters from pHippy on either end of a PCR prod-
uct. A gene-specific primer for a target gene can be sand-
wiched between the two convergent promoters. To
develop this system three oligonucleotides were synthe-
sized: 1) a 97 nt primer consisting of the entire H1 pro-
moter from pHippy, 2) a gene-specific primer containing
18 nt of complimentary sequence to both the H1 and U6
promoters and 21 nt of gene-specific (PGL3 luciferase) or
random control sequences, and 3) an 18 nt anti-sense
primer to the human U6 promoter (Fig. 4a). After PCR
with H1, U6, and limiting amounts of the gene-specific
primer using a U6 template, a single robust band was gen-
erated for all of the different gene-specific primers of theBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/16
Page 6 of 11
(page number not for citation purposes)
Assays to determine if pHippy can be used to inhibit endogenous genes Figure 3
Assays to determine if pHippy can be used to inhibit endogenous genes. a, Renilla luciferase assays to determine if any of 5 
unique pHippy constructs against Human LRP6 inhibit activity of a fusion of LRP6 to Renilla luciferase. 293T were co-trans-
fected with the vectors shown and assayed for luciferase activity 48 hours later. Cells co-transfected with LRP6Rluc and empty 
pHippy were set to 100%. All experiments were normalized for transfection with PGL3 luciferase. The average normalized 
Renilla luciferase levels and standard deviation are shown for 3 experiments. b, Determination of whether inhibition of endog-
enous LRP6 inhibits Wnt3a activation of the Wnt/β-catenin signaling pathway. 293T cells were co-transfected with the vectors 
shown, Super(8X)Topflash (to measure Wnt/β-catenin-signaling), and a constitutive expression vector for Renilla luciferase. 24 
hours after transfection the cells were treated with Wnt3a conditioned media for 24 hours and then assayed for luciferase 
activity. Untreated cells transfected with empty vector were set to 1 fold activation of Super(8X)Topflash, which corresponds 
to ~10,000 RLUs. Cells treated with Wnt3a induce about 100 fold-activation of luciferase as shown. All experiments were nor-
malized for transfection efficiency with the Renilla luciferase expression vector. One representative experiment is shown.
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A high throughput system to generate pHippy expression cassettes Figure 4
A high throughput system to generate pHippy expression cassettes. a, A multiple primer PCR system was used to generate 
PCR products that express siRNA after transfection into cells. A 5' primer (U6 primer) was designed to human U6. A second 
primer (gene specific) was designed with sequences that are complementary to the 3' end of the human 6 promoter, the target 
siRNA sequence, and a sequence that is complementary to the 3' of the human H1 promoter. A third primer was designed that 
contains the human H1 promoter and is complementary to the gene specific primer. b, An agarose gel stained with ethidium 
bromide demonstrates the robustness of the PCR method for several different gene specific primers. c, A luciferase assay as 
described in the legend to Figure 3b to determine if the PCR products inhibit PGL3 luciferase activity.
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appropriate size (Fig. 4b). These PCR products were
cleaned with a nucleospin column and co-transfected into
293T cells with the PGL3 luciferase reporter and Renilla
luciferase as a normalization control. Neither of the con-
trol PCR products significantly inhibited PGL3 luciferase
activity (Fig. 4c). However, the PCR product generated
against PGL3 luciferase inhibited luciferase in a dose-
dependent manner (Fig. 4c). Although the pHippy PCR
cassette against PGL3 luciferase inhibited PGL3 luciferase
expression, it was not as efficient as the pHippy vector
directed against PGL3 luciferase (Fig. 4c). This may be due
to faster degradation of the PCR product and might be cir-
cumvented by additional sequences on the 5' and 3' ends
of the PCR product.
Generation of random siRNA-libraries in pHippy
The pHippy system is well-suited for generation of cDNA
or random siRNA libraries because both strands of DNA
template are transcribed to generate siRNA. To determine
if pHippy could in principle be used for a random screen,
a random library of siRNAs based on PGL3 luciferase was
generated (Fig. 5a). This library was generated by rand-
omizing 3 nt in the functional PGL3 siRNA described in
Figure 2 and corresponds to a library of 64 possible siR-
NAs. To determine if this library could be screened to
recover siRNA activity, 130 randomly chosen clones from
E. coli containing the library were picked and pooled in
groups of 10. These 13 pools were screened for their abil-
ity to inhibit PGL3 luciferase activity. The library consists
of a maximum of 64 possible siRNAs and only 2 of the
pools from the 130 clones would be predicted to inhibit
PGL3 luciferase activity. In agreement with this calcula-
tion, pools 8 and 11 had significant inhibitory activity
(Fig. 5b). These pools of 10 were further reduced to single
clones and each individual clone was re-screened for
inhibitory activity. Pool 8 contained one clone that had
inhibitory activity and pool 11 contained two clones with
inhibitory activity. Sequencing of these three clones
revealed that these clones contained the original sequence
against PGL3 (Fig 5c). In contrast, 10 clones that did not
inhibit PGL3 luciferase activity had random sequences at
the mutant positions (Fig. 5c).
These experiments demonstrate that the pHippy system
can be used for random siRNA screens. Specifically, librar-
ies can be generated where all of the 21 nt of the siRNA are
random. This library would encompass multiple targets in
every gene in the human genome and could be used for
phenotypic single cell assays to identify genes required for
the screened phenotype, without first knowing the siRNA
sequence. For instance, a random siRNA library could be
used to identify genes required for Wnt signaling by
screening for siRNAs that inhibit the ability of Wnt to acti-
vate Super(8X)Topflash.
Conclusions
pHippy is an siRNA expression vector, which utilizes con-
vergent promoters to generate functional siRNAs by driv-
ing expression from both strands of the same template
DNA. In tests to date, pHippy vectors directed against
PGL3 luciferase knock down the expression of luciferase
better than hairpin RNAs. This is likely because pHippy
produces functional siRNA that do not need to be cleaved
by Dicer. In addition, pHippy vectors against any target
gene are easier to generate than with hairpin vectors. Spe-
cifically, the oligos needed to generate pHippy siRNA vec-
tors are shorter and more cost effective, and the final
clones are easier to identify and sequence. pHippy expres-
sion cassettes can be generated in a high throughput man-
ner by PCR without the need to propagate through
bacteria.
We have used pHippy to knock out the expression of an
endogenous Wnt pathway co-receptor, as scored by meas-
uring effects on a Wnt pathway reporter, thereby validat-
ing this approach for endogenous targets. siRNAs
synthesized from pHippy are predicted to have fewer off-
target effects than some siRNA approaches since pHippy-
derived siRNAs have no extraneous nucleotides, a feature
one might design into vectors developed with gene ther-
apy as a goal.
One of the biggest advantages is that pHippy can be used
to generate random and cDNA siRNA expression libraries,
which can be used to identify genes involved in any bio-
logical phenomena that can be screened by phenotype. As
a proof of principle we screened a small random siRNA
library for siRNAs that inhibit PGL3 luciferase activity,
and were able to recover functional siRNAs that knocked
down activity of this target. This approach can now be
used to identify siRNAs that modulate diverse biological
phenomena.
Methods
Cell culture and transfection
293T cells were grown in DMEM supplemented with 10%
FBS and 1% Penicillin/Streptomycin under standard con-
ditions. All transfections were performed in 24 well plates
with Lipofectamine Plus or 2000 (Invitrogen) according
to the manufacturer's specifications.
Confocal microscopy
2.5. × l05 293T cells were seeded in 12 well plates and
transfected with 10 ng of pEGFPNl (Clontech),
pDSREDNl (Clontech), and 30 ng of the indicated siRNA
construct. 24 hours after transfection the cells were
removed from the plates with PBS and live cells were
sandwiched between cover-slips and glass slides and visu-
alized for fluorescence using the appropriate lasers and fil-
ters to visualize EGFP and DSRED.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/16
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A siRNA screen was conducted with a small siRNA library against PGL3 luciferase Figure 5
A siRNA screen was conducted with a small siRNA library against PGL3 luciferase. a, Depiction of the small siRNA library 
against PGL3 luciferase. The target sequence for the siRNA against PGL3 siRNA that was tested in Figure 3b is shown. The 
bases in bold were randomized by synthesizing an oligo with random bases in place of CTC and cloned into the pHippy vector. 
b, Screening of the siRNA library. 12 pools of 10 bacterial colonies from the random siRNA library against PGL3 luciferase 
were screened for their ability to inhibit PGL3 luciferase activity as described in the legend to Figure 3b. c, The sequences of 
the siRNA single clones, which did or did not inhibit PGL3 luciferase. Pools 8 and 11 were broken down into individual clones 
and re-screened for inhibitory activity. Pool 8 contained 1 positive clone and Pool 11 contained 2 positive clones. The 
sequences of all three positive clones is shown on the left and corresponds to the original PGL3 siRNA. The sequences of 10 
negative clones are shown on the right.
0
20
40
60
80
100
120
140
160
123456789 1 0 1 1 1 2 1 3
% Luciferase
Activity
Pool #
Neg Pos
AAGGCTCCTCAGAAACAGNNN
CCGAGGAGTCTTTGTCNNNAA
a.
b.
c.
AAGGCTCCTCAGAAACAGCTC
CCGAGGAGTCTTTGTCGAGAA
PGL3Luc siRNA
PGL3Luc siRNALibrary
NNN NNN
1. CTC
2. CTC
3. CTC
1.ACG 2.AAG
3. TCG 4. GGG
5. GCC 6. CCG
7. CCG 8. TTG
9. CCC 10. GGT
Sequence from single rescued clones after deconvolution
Positive clones Negative clonesBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/16
Page 10 of 11
(page number not for citation purposes)
Reporter assay
Luciferase assays were preformed according to the Dual
luciferase assay specifications (Promega). In all cases 293T
cells were transfected with 10 ng of CMV-PGL31uciferase
and 100 pg of pRLCMV (Promega), and the cells were har-
vested 24 hours later and assayed for luciferase activity in
96 well plate in a Berthold 96 V luminometer.
Super(8X)Topflash reporter assays were performed as
described [23]. 293T cells seeded in 24 well plates were
transfected with 10 ng of Super(8X)Topflash, 100 pg of
pRLCMV (Promega), and the indicated amount of effecter
plasmids. The concentrations of all transfections were
brought up to a total of 250 ng with the vector CS2+.
Assays were performed as described [23] and according to
the Dual luciferase assay specifications (Promega).
Multiple primer PCR
pHippy siRNA expression cassettes were generated by a
single step multiple primer PCR. In short, a 10 ng of plas-
mid containing the human U6 promoter was used as tem-
plate for PCR in a 50 µl reaction containing 2 µl of 10 pm/
µl U6 primer, 2 µl of a primer encompassing the entire H1
promoter, 2 µl of 0.01 pm/µl of the gene-specific linker
primer, 10 µl of 2 mM DNTPs, 10 µl of advantage buffer,
and 0.5 µl tag-advantage (Clontech). The PCR products
were generate by 30 cycles of touchdown PCR program
that ramped down from 60°C to 50°C.
RNAi design and recombinant DNA constructs
All recombinant constructs were generated by standard
recombinant DNA techniques. The sequences of pHippy
will be provided upon request. siRNAs were designed
using the web based siRNA design program from the
Whitehead Institute web page http://jura.wi.mit.edu/
pubint/http://iona.wi.mit.edu/siRNAext/home.php. In
general, siRNAs were used from previously published siR-
NAs or were designed by introducing the corresponding
sequence for a given gene into the Whitehead siRNA
design program using the following pattern AAN19TT or
AAGN17CN2. The output sequences for a given gene that
were not complimentary to other genes after blasting were
chosen, and the corresponding oligos were designed and
ordered. Oligos were based on the Whitehead output
sequences and modified for cloning into pHippy by addi-
tion of 2 or 4 adenines to the 5' end of the sense and anti-
sense versions of the Whitehead output sequences. Oligos
used; PGL3luciferase, sense
(5'AAaaggctcctcagaaacagctc3'), antisepses
(5'AAaagagctgtttctgaggagcc3'): EGFP, sense (5'
AAaagcaagctgaccctgaagttcat3'), antisense (5'
AAaaatgaacttcagggtcagcttgc3'): LRP6#1 sense
(5'AAaaaggttcccttccacatcct3'), antisense
(5'AAaaaggatgtggaagggaacct3'): LRP6#2 sense
(5'AAaaaaggttcccttccacatccttt3'), antisense
(5'AAaaaaggatgtggaagggaaccttt3'): LRP6#3 sense
(5'AAaagaagatggcagccagggct3'), antisense
(5'AAaaagccctggctgccatcttc3'): LRP6#4 sense
(5'AAaaggcacttacttccctgcaa3'), antisense
(5'AAaattgcagggaagtaagtgcc3'): LRP6#5 sense
(5'AAaaaaggcacttacttccctgcaatt3'), antisense
(5'AAaaaattgcagggaagtaagtgcctt3').
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